Trials / Unknown
UnknownNCT05296993
Safety & Efficacy of Extended Longevity Protocol
The Safety and Effectiveness of the Extended Longevity Protocol on the Epigenetic Aging Rate in Healthy Individuals
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- TruDiagnostic · Industry
- Sex
- All
- Age
- 55 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to quantifiably determine if the Extended Longevity Protocol has a significant clinical effect on epigenetic age.
Detailed description
This is a prospective non-randomized clinical study of 15 patients to determine if the safety and effectiveness of the Extended Longevity Protocol's impact on the nine determinant factors of aging can decelerate aging. There is evidence that the Extended Longevity Protocol decelerates aging and the risk of age-related diseases. The aim of this pilot study is to evaluate the safety, efficacy and feasibility of the Extended Longevity Protocol as an effective treatment option to improve clinical care of healthy individual's biological age thus prolonging longevity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Extracts found in the Extended Longevity supplements | Ingredients found in these serums are all naturally occurring, and extracted from a variety of plant species. |
Timeline
- Start date
- 2021-05-25
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2022-03-25
- Last updated
- 2022-05-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05296993. Inclusion in this directory is not an endorsement.